Trajectories of disability and relapse-rate in naïve patients on oral drugs: results from the Italian Multiple Sclerosis Register (P17-4.003) — Alessia Manni (2022) | RDL Network
Trajectories of disability and relapse-rate in naïve patients on oral drugs: results from the Italian Multiple Sclerosis Register (P17-4.003)
Article 2022 en
Authors
AM
Alessia Manni
DP
Damiano Paolicelli
GL
Giuseppe Lucisano
Abstract
1 min read
To evaluate the long-term effect of different oral disease-modifying therapies (DMTs) on trajectories of disability and relapses in a large naïve Multiple Sclerosis (MS) population.
Emanuele D’Amico, Aurora Zanghì, Marzia Romeo, Eleonora Cocco, Giorgia Teresa Maniscalco, Vincenzo Brescia Morra, Damiano Paolicelli, Giovanna De Luca, Simonetta Galgani, Maria Pia Amato, Giuseppe Salemi, Matilde Inglese, Paolo Confalonieri, Giacomo Lus, Carlo Avolio, Antonio Gallo, Marika Vianello, Marco Onofrj, Massimo Filippi, María Trojano, Francesco Patti
Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa, María Trojano
Damiano Baroncini, Pietro Iaffaldano, Marta Simone, Vincenzo Brescia Morra, Massimo Filippi, Marzia Romeo, Francesco Patti, Clara Grazia Chisari, Eleonora Cocco, Giuseppe Fenu, Giuseppe Salemi, Paolo Ragonese, Matilde Inglese, Maria Cellerino, Gıancarlo Comı, Mauro Zaffaroni, Angelo Ghezzi
Ermelinda De Meo, Massimo Filippi, Vincenzo Brescia Morra, Francesco Patti, Giorgia Teresa Maniscalco, Valentina Torri Clerici, Giuseppe Salemi, Marco Onofrj, Giacomo Lus, Marta Simone, María Trojano, Maria Pia Amato
Discussion(0)
No comments yet. Be the first to comment.